BioCentury
ARTICLE | Company News

Xoma Ltd., Roche deal

September 21, 2009 7:00 AM UTC

Xoma sold its royalty rights to Lucentis ranibizumab to Roche's Genentech Inc. unit for $25 million. Xoma will use the money to help repay a $44.2 million loan to Goldman Sachs. Xoma expects to repa...